LSGRX
Price
$33.78
Change
+$0.07 (+0.21%)
Updated
Dec 24 closing price
Net Assets
18.49B
RGEBX
Price
$77.54
Change
+$0.22 (+0.28%)
Updated
Dec 24 closing price
Net Assets
338.91B
Interact to see
Advertisement

LSGRX vs RGEBX

Header iconLSGRX vs RGEBX Comparison
Open Charts LSGRX vs RGEBXBanner chart's image
Loomis Sayles Growth Y
Price$33.78
Change+$0.07 (+0.21%)
VolumeN/A
Net Assets18.49B
American Funds Growth Fund of Amer R2E
Price$77.54
Change+$0.22 (+0.28%)
VolumeN/A
Net Assets338.91B
LSGRX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
LSGRX vs. RGEBX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSGRX is a Hold and RGEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 339B vs. LSGRX (18.5B). LSGRX (0.00) and RGEBX (0.00) have matching dividends . LSGRX was incepted earlier than RGEBX: LSGRX (35 years) vs RGEBX (11 years). RGEBX (1.08) is less costly to investors than LSGRX (0.67). RGEBX is a more actively managed with annual turnover of: 32.00 vs. LSGRX (7.00). RGEBX has a lower initial minimum investment than LSGRX: RGEBX (250) vs LSGRX (100000). LSGRX annual gain was more profitable for investors over the last year : 9.93 vs. RGEBX (5.18). LSGRX return over 5 years is better than : 48.22 vs. RGEBX (19.19).
LSGRXRGEBXLSGRX / RGEBX
Total Expense Ratio0.661.0861%
Annual Report Gross Expense Ratio0.671.0862%
Fund Existence35 years11 years-
Gain YTD14.2768.539167%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets18.5B339B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.935.18192%
Returns for 3 years107.7562.27173%
Returns for 5 years48.2219.19251%
Returns for 10 years195.7988.81220%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD4.600.11
+2.45%
Relmada Therapeutics
TPCS4.660.05
+1.08%
TechPrecision Corp
FSLY10.540.11
+1.05%
Fastly
PNFP101.300.05
+0.05%
Pinnacle Financial Partners
OYSEU10.45N/A
N/A
Oyster Enterprises II Acquisition Corp